Therapeutic Solutions International Announces Landmark Finding Regarding Mechanism of Action of its JadiCell Stem Cell Product
Potent Activation of Naturally Occurring “Healing Cells” That Amplify Therapeutic Effects of Stem Cells Discovered
Using the inflammation-induced lung injury model, the Company found that JadiCell administration caused an increase in monocytes expressing the cytokine interleukin-35 as well as T cells expressing an anti-inflammatory molecule called TGF-beta. Depletion of either of these cells significantly reduced therapeutic effects of JadiCells. Additionally, transfer of monocytes and T cells from JadiCell treated mice was able to protect naïve mice from lung injury. The therapeutic effect of JadiCells was amplified by administration of Leukine (GM-CSF), which is known to increase circulating monocytes.
“The data announced today, for which we have filed an additional patent, represents a major step in elucidating the mechanisms of how this incredible cell functions biologically,” said Dr.
The Company has licensed the issued
“Understanding yet another mechanism of how our therapeutic product functions, provides additional intellectual property, new ways of increasing its efficacy, as well as potentially accelerating development through regulatory agencies,” said
About
1 https://www.yalemedicine.org/conditions/ards#
View source version on businesswire.com: https://www.businesswire.com/news/home/20240229283223/en/
ir@tsoimail.com
Source: